TipRanks
Adaptive Biotechnologies Corp (DE:1HM)
FRANKFURT:1HM

Compare Adaptive Biotechnologies (1HM) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Adaptive Biotechnologies
€22.19
€3.74B
-64.04
92.11%
8 Buy
1 Hold
0 Sell
Strong Buy
AbCellera Biologics
$12.50
$4.16B
-22.26
94.81%
8 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$3.56
$2.29B
-3.80
-35.14%
2 Buy
3 Hold
0 Sell
Moderate Buy
Ginkgo Bioworks Holdings
$7.54
$772.39M
-2.26
-29.52%
0 Buy
1 Hold
2 Sell
Moderate Sell
Caris Life Sciences, Inc.
$28.01
$7.66B
73.94
-16.54%
6 Buy
3 Hold
0 Sell
Moderate Buy
Alamar Biosciences, Inc.
$30.54
$1.93B
-48.89
17.77%
3 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1HM
Adaptive Biotechnologies
23.38
10.24
77.86%
ABCL
AbCellera Biologics
12.02
6.49
117.36%
RXRX
Recursion Pharmaceuticals
3.95
-1.37
-25.75%
DNA
Ginkgo Bioworks Holdings
11.34
-2.18
-16.12%
CAI
Caris Life Sciences, Inc.
27.50
-2.98
-9.78%
ALMR
Alamar Biosciences, Inc.
25.91
3.91
17.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts